Nothing Special   »   [go: up one dir, main page]

Reindel et al., 1991 - Google Patents

The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.

Reindel et al., 1991

View PDF
Document ID
8312376334171378042
Author
Reindel J
Roth R
Publication year
Publication venue
The American journal of pathology

External Links

Snippet

Monocrotaline pyrrole (MCTP), a reactive electrophile, induces delayed and progressive pulmonary edema, vascular remodeling, and pulmonary hypertension after a single intravenous administration to rats. The effects of a single exposure of cultured bovine …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Reindel et al. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
Bavister et al. The effects of sperm extracts and energy sources on the motility and acrosome reaction of hamster spermatozoa in vitro
Schultze et al. Chronic pulmonary hypertension‐the monocrotaline model and involvement of the hemostatic system
Pakala et al. Mitogenic effect of serotonin on vascular endothelial cells.
Yang et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection.
Wachstein et al. Succinic dehydrogenase activity in myocardial infarction and in induced myocardial necrosis
Oreffo et al. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts
Robinson Improved localization of intracellular sites of phosphatases using cerium and cell permeabilization.
JP7009463B2 (en) Reagents, compositions, and methods for improving the viability and function of cells, tissues, and organs.
Endo et al. The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse.
US5565448A (en) Medicament
McElroy et al. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechanism of inhibition of platelet function
Spry et al. The cardiotoxicity of eosinophils
Di Sario et al. Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat
Moncada et al. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis
Tolins et al. Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Update on humoral regulation of vascular tone.
Tschopp et al. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production
Zehr et al. NEUTROPHIL ADHESION AND COMPLEMENT INHIBITION PROLONGS SURVIVAL OF CARDIAC XENOGRAFTS IN DISCORDANT SPECIES1
Elmore et al. Cryopreservation affects endothelial and smooth muscle function of canine autogenous saphenous vein grafts
Gobbel et al. Response of cerebral endothelial cells to hypoxia: modification by fructose-1, 6-bisphosphate but not glutamate receptor antagonists
Pan et al. TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C
Babbitt et al. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical.
US20230210105A1 (en) Cryopreserving macrophages
US5616577A (en) Protein Kinase C inhibitor
Ganey et al. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia